2021年唾液腺恶性肿瘤两种国际指南的解读与比较  

Interpretation and comparison of international guidelines for salivary gland malignancy in 2021

作　　者：王雅慧 李志勇 陈谦明 Wang Yahui;Li Zhiyong;Chen Qianming(Stomatology Hospital,School of Stomatology,Zhejiang University School of Medince&Clinical Research Center for Oral Diseases of Zhejiang Province&Key Laboratory of Oral Biomedical Research of Zhejiang Province&Cancer Center of Zhejiang University,Hangzhou 310006,China;Department of Oral Oral and Maxillofacial Surgery,Stomatology Hospital,School of Stomatology,Zhejiang University School of Medince&Clinical Research Center for Oral Diseases of Zhejiang Province&Key Laboratory of Oral Biomedical Research of Zhejiang Province&Cancer Center of Zhejiang University,Hangzhou 310006,China)

机构地区：[1]浙江大学医学院附属口腔医院·浙江大学口腔医学院,浙江省口腔疾病临床医学研究中心,浙江省口腔生物医学研究重点实验室,浙江大学癌症研究院,杭州310006 [2]浙江大学医学院附属口腔医院口腔颌面外科·浙江大学口腔医学院,浙江省口腔疾病临床医学研究中心,浙江省口腔生物医学研究重点实验室,浙江大学癌症研究院,杭州310006

出　　处：《中华口腔医学杂志》2022年第2期136-141,共6页Chinese Journal of Stomatology

摘　　要：为给唾液腺恶性肿瘤(salivary gland malignancy,SGM)的诊疗提供循证建议,2021年美国临床肿瘤学会和美国国家综合癌症网分别制订和更新了SGM临床实践指南。本文从SGM的术前评估、手术治疗、放射治疗、系统性治疗、随访和复发转移性疾病诊疗等角度出发,对两种指南进行解读和比较分析,旨在为我国SGM的诊疗提供临床指导。In order to provide evidence-based recommendations on the management of salivary gland malignancy(SGM),the American Society of Clinical Oncology(ASCO)and the National Comprehensive Cancer Network(NCCN)formulated and updated SGM clinical practice guidelines respectively in 2021.The two guidelines are interpreted and compared in this article from six perspectives including preoperative evaluations,surgical diagnostic and therapeutic procedures,appropriate radiotherapy techniques,the role of systemic therapy,follow-up evaluations and recurrent-metastatic diseases′management of SGM,which has guiding significance for diagnosis and treatment of SGM in China.

关 键 词：唾液腺 恶性肿瘤 实践指南 

分 类 号：R739.87[医药卫生—肿瘤]